Current usage of antimicrobial combinations in pediatrics.
D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D004336:Drug Antagonism; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D066298:In Vitro Techniques; D007231:Infant, Newborn; D007740:L Forms / Q000187:drug effects; D008581:Meningitis / Q000188:drug therapy; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D010406:Penicillins; D014295:Trimethoprim; D013420:Sulfamethoxazole